Revolution Medicines Inc (RVMD) Stock Analysis

Revolution Medicines Inc (RVMD) is a publicly traded company in the HEALTHCARE sector. It trades at $151.31, carries a market capitalization of $34.80B. This page summarizes the public market data, fundamentals, and frequently asked questions for RVMD, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Revolution Medicines Inc currently has a Bullish sentiment score of 0.40.

About Revolution Medicines Inc

Revolution Medicines, Inc. is a clinical-stage oncology company headquartered in Redwood City, California, specializing in the development of innovative therapies targeting RAS-addicted cancers. With a commitment to harnessing precision medicine, the company's pipeline includes novel treatments designed to inhibit previously deemed "undruggable" targets, positioning it at the forefront of cancer therapeutics. Revolution Medicines is dedicated to improving outcomes for patients through its rob...

GNG Research Analysis

GNG Research scores Revolution Medicines Inc (RVMD) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for RVMD.

Frequently Asked Questions

Does RVMD pay dividends?

Revolution Medicines Inc (RVMD) does not currently pay a regular dividend.

What is RVMD's market cap?

Revolution Medicines Inc (RVMD) has a market capitalization of $34.80B with a current stock price of $151.31.